Training activity information
Details
Select and interpret diagnostic techniques for the investigation of dietary-related anaemia
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
What are the intended outcomes of the training activity?
- How will you focus your attention on identifying appropriate clinical investigations for acquired red cell disorders and performing essential quality assurance tasks across these investigations?
- In what ways will exploring the indicative content—such as iron metabolism, iron deficiency, B12/folate metabolism, and pernicious anaemia—help guide your preparation for this task?
- What specific knowledge do you need before embarking on the activity, such as the biochemical markers of nutrition (e.g. Ferritin, B12, Folate) and the morphological indicators of dietary anaemia?
- How will this activity help you define success in providing a diagnostic interpretation that outlines the management of red cell disorders in the correct clinical context?
What do you anticipate you will learn from the experience?
- What specific insights do you hope to gain regarding the selection of follow-up tests (e.g. anti-intrinsic factor antibodies or iron studies) when initial full blood count results suggest a dietary cause?
- Based on your current knowledge, how do you anticipate this activity will deepen your understanding of the pathogenesis of anaemia of chronic disease versus true nutritional deficiency?
- In what ways will this activity prepare you for the high-level analytical responsibilities required to ensure reliable results through the performance of IQC and EQA for automated haematinic assays?
What actions will you take in preparation for the experience?
- How will you discuss the diagnostic protocols and laboratory workflows for anaemia investigation with your Training Officer or assessor to ensure you have a clear understanding of what is expected?
- What possible challenges have you identified—such as interpreting results in patients with concurrent inflammatory states or mixed deficiencies—and how do you plan to handle them?
- Which national guidelines (e.g. BSH guidelines on the investigation and management of iron, B12, or folate deficiency) will you review to ensure your interpretations are evidence-based?
- How do you feel about embarking on this training activity? Does acknowledging feelings of curiosity regarding the clinical impact of these common disorders help you focus on the technical precision required?
In action
What are you doing?
- As you select and perform the tests, are the diagnostic techniques you are using appropriate for investigating anaemia with a suspected dietary link, such as iron studies, B12, or folate assays?
- How are you ensuring that your approach to selecting these investigations identifies the correct underlying cause of acquired red cell disorders?
- What decisions are you making as the results (e.g. FBC indices, iron studies, or haematinic levels) become available regarding the need for further confirmatory testing, such as anti-intrinsic factor antibodies?
- Which aspects of your practice feel intuitive, such as identifying microcytic or macrocytic features on a film, and what requires more conscious effort, such as interpreting results in the context of anaemia of chronic disease or hepcidin influence?
How are you progressing with the activity?
- How effective are your actions in achieving a definitive laboratory picture that outlines the pathogenesis of the anaemia?
- How are you performing quality assurance and control tasks while the investigation is underway, such as verifying that IQC and EQA for the haematinic analysers are within acceptable limits before you interpret the patient’s results?
- What challenges are you facing—such as identifying mixed deficiencies or resolving conflicting data between ferritin levels and inflammatory markers—and what can you learn from these as they unfold?
- How does this investigation connect to your existing knowledge of iron, B12, and folate metabolism and the indicative content of the curriculum?
How are you adapting to the situation?
- If you encounter unexpected results (e.g. a low B12 with a normal MCV), how are you adapting your strategy to consider alternative interpretations or the need for further red cell investigations?
- Are you working within your defined scope of practice, and at what point do you recognise that you need support or guidance from a senior colleague to outline the management of the disorder?
- How are you adapting your interpretive approach to ensure the final report clearly identifies the investigations performed and provides a basis for the clinical management of the patient?
- Are you considering the limitations of the tests you are performing—such as drug interference in folate metabolism—as the activity unfolds?
On action
What did you notice?
- What were the key clinical features and full blood count (FBC) indices—such as microcytosis or macrocytosis—that initially suggested a dietary-related anaemia?
- Which specific diagnostic techniques did you select and perform, such as iron studies (ferritin, transferrin saturation), B12, and folate assays?
- What were the significant findings (e.g. low ferritin or borderline B12 levels), and did any results contradict your initial suspicions?
- Regarding Quality Assurance, did you verify that the internal quality control (IQC) and external quality assurance (EQA) for the automated haematinic assays were within acceptable limits before you interpreted the patient’s data?
- Were there any reflect-in-action moments during the process where you had to adapt your strategy, such as investigating a mixed deficiency pattern?
What did you learn from the activity?
- What did you learn about the specific laboratory markers and the pattern of results (e.g. iron deficiency vs anaemia of chronic disease) used to identify acquired red cell disorders?
- How has this experience improved your ability to outline the management of dietary-related anaemias in the correct clinical context?
- What did you learn about the pathogenesis of these disorders, including the roles of iron, B12, and folate metabolism, and how inflammation or hepcidin can influence results?
- Were there unexpected challenges, such as interpreting results in patients with limited clinical history, and how did these impact your interpretation?
- How does the ability to synthesise these results and recommend further testing (e.g. anti-intrinsic factor antibodies) relate to the high-level analytical requirements of post-programme practice?
What will you take from the experience moving forward?
- How will this activity enhance your future approach to selecting investigations for patients with suspected nutritional or hereditary red cell disorders?
- What specific resources or guidelines (e.g. BSH guidelines on iron, B12, or folate deficiency) have you identified as essential for supporting your routine practice?
- What actions or ‘next steps’ will you take to further your development, such as studying the impact of drug interference on folate metabolism or the investigation of hereditary red cell defects?
- How will you apply your learning regarding quality assurance and control to ensure that the monitoring of treatment response in anaemic patients remains reliable?
- How has this experience changed your perspective on the partnership between laboratory findings and clinical management in restoring a patient’s haematological health?
Beyond action
Have you revisited the experiences?
- Since completing this investigation, have you encountered further cases of dietary-related anaemia, perhaps involving complex mixed deficiencies or anaemia of chronic disease?
- How has your understanding of the pathogenesis and metabolism of iron, B12, and folate evolved as you have reviewed your initial reflections for this activity?
- Can you recall professional storytelling sessions with peers or senior colleagues regarding challenging cases where haematinic results (e.g., borderline B12 or high ferritin in inflammation) were difficult to interpret?
- As part of a module review for Specialist Haematology (S-HT-S2), how does your experience with dietary anaemia connect to your learning regarding other red cell disorders, such as haemoglobinopathies or bone marrow failure?
- Have you reviewed updated BSH, WHO, or NICE guidelines to see if the diagnostic algorithms you used remain the gold standard for clinical investigation?
How have these experiences impacted upon your current practice?
- How has this training activity enhanced your ability to identify appropriate clinical and laboratory investigations (e.g., iron studies, anti-intrinsic factor antibodies) for acquired red cell disorders in the correct clinical context?
- In what ways has your focus on quality assurance and control matured, particularly in ensuring IQC and EQA for automated haematinic assays are robust before results are released?
- How has the cumulative learning from these experiences supported your preparation for observed ‘in-person’ assessments, such as a Case-based Discussion (CBD) or a DOPS focused on morphological investigation?
- Are you now more adept at outlining the management of these disorders, such as identifying when oral versus parenteral replacement is recommended based on laboratory findings?
- How has your ability to recognise morphological and biochemical patterns suggestive of specific deficiencies evolved through these repeated experiences?
How might these experiences contribute towards your future practice?
- How will your experience in selecting and interpreting diagnostic techniques for anaemia prepare you for a role where you may need to lead on method validation for new haematinic assays?
- Will your ability to accurately interpret complex diagnostic data contribute to more effective patient management and risk stratification in future specialist practice?
- What clear actions for continued development have you identified, such as staying updated on emerging markers like hepcidin or new technologies for assessing iron status?
- How might this foundational experience support your progression towards a specialist role, where you are responsible for implementing national screening or diagnostic protocols within the laboratory?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 6 |
Outcome
Identify appropriate clinical and laboratory investigations and outline the management of acquired and hereditary red cell disorders. |
| # 7 |
Outcome
Perform quality assurance and control tasks across the range of investigations. |